Salomon D S, Sherman M I
Endocrinology. 1976 Sep;99(3):800-8. doi: 10.1210/endo-99-3-800.
The ability of cultured midpregnancy mouse ovarian cells to synthesize progesterone de novo and from oxogenous pregnenolone has been assessed. The conversion of pregnenolone to progesterone is almost completely blocked by cyanoketone, a known inhibitor of delta5,3beta-hydroxysteroid dehydrogenase (3beta-HSD) activity, but is unaffected by aminoglutethimide, which inhibits the cholesterol side-chain cleavage enzyme complex (desmolase). Since there is little metabolism of the formed progesterone, the ability of ovarian cells to convert exogenous pregnenolone to progesterone in vitro reflects the activity of 3beta-HSD in these cells. Cultured ovarian cells are also capable of endogenous progesterone production in the absence of added pregnenolone, although the absolute amount of progesterone produced is considerably less than that produced from exogenous pregnenolone. Since endogenous progesterone accumulation is almost completely blocked by the addition of aminoglutethimide to the culture medium, it is concluded that this response does represent de novo progesterone synthesis. Neither bovine luteinizing hormone (LH) nor human chorionic gonadotrophin (hCG) affects 3beta-HSD activity in cultured ovarian cells. The ability of the cells to secrete or to further metabolize the progesterone formed is also unaffected. However, both LH and hCG stimulate endogenous progesterone production within one hour of their addition to the culture medium. The stimulation, 2-10 fold in several experiments, can be maintained for at least six days of culture, and is not a result of an increase in the growth rate of the ovarian cells. As would be expected, the stimulation is blocked by the addition of aminoglutethimide to the culture medium. Taken together, these facts suggest that gonadotrophic hormones stimulate progesterone production by ovarian cells specifically by their action at steps prior to the conversion of pregnenolone to progesterone.
已对培养的妊娠中期小鼠卵巢细胞从头合成孕酮以及从外源性孕烯醇酮合成孕酮的能力进行了评估。孕烯醇酮向孕酮的转化几乎完全被氰酮阻断,氰酮是已知的δ5,3β - 羟基类固醇脱氢酶(3β - HSD)活性抑制剂,但不受氨基导眠能影响,氨基导眠能抑制胆固醇侧链裂解酶复合物(desmolase)。由于生成的孕酮几乎没有代谢,卵巢细胞在体外将外源性孕烯醇酮转化为孕酮的能力反映了这些细胞中3β - HSD的活性。培养的卵巢细胞在不添加孕烯醇酮的情况下也能够产生内源性孕酮,尽管产生的孕酮绝对量远低于从外源性孕烯醇酮产生的量。由于向培养基中添加氨基导眠能几乎完全阻断了内源性孕酮的积累,因此得出结论,这种反应确实代表了孕酮的从头合成。牛促黄体生成素(LH)和人绒毛膜促性腺激素(hCG)均不影响培养的卵巢细胞中3β - HSD的活性。细胞分泌或进一步代谢生成的孕酮的能力也不受影响。然而,LH和hCG在添加到培养基后一小时内均刺激内源性孕酮的产生。在几个实验中,这种刺激作用为2 - 10倍,并且可以在至少六天的培养中维持,并且不是卵巢细胞生长速率增加的结果。正如预期的那样,向培养基中添加氨基导眠能可阻断这种刺激作用。综上所述,这些事实表明促性腺激素通过卵巢细胞刺激孕酮的产生,具体是通过它们在孕烯醇酮转化为孕酮之前的步骤中的作用。